The circulating levels of the platelet activation markers PF4 and sP-selectin were highly elevated among our cohort of COVID-19–positive patients compared to controls which further supports the hypothesis that COVID-19 is associated with enhanced platelet activation. This evidence concerns the gene PF4 and COVID-19.